PREVENT HPV -Related Cancers Trial
NCT07217145 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1455
Last updated 2026-04-07
Summary
This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, our intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States.
The proposed study will assess the effectiveness of a clinic-based behavioral outreach intervention to increase HPV vaccination rates at community clinics in rural counties. The intervention consists of communication and engagement strategies delivered within routine care settings and is designed to pose no more than minimal risk to participants.
Conditions
- HPV Vaccination
- Uptake Vaccination
- Series Completion
Interventions
- BEHAVIORAL
-
PREVENT
The proposed study will assess the effectiveness of clinic-based outreach to increase vaccination rates for HPV at community clinics in rural counties.
Sponsors & Collaborators
-
Kaiser Permanente
collaborator OTHER -
University of Arizona
collaborator OTHER -
Sea Mar Community Health Centers
collaborator OTHER -
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Deanna Kepka, PhD, MPH · University of Utah
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-10-09
- Primary Completion
- 2026-02-01
- Completion
- 2026-07-01
Countries
- United States
Study Locations
More Related Trials
-
Increasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise
NCT03604393 ·Status: UNKNOWN ·Phase: NA
-
Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
NCT00122681 ·Status: COMPLETED ·Phase: PHASE3
-
Improving HPV Vaccination Rates Among Rural and Native American Adolescents
NCT03801603 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women
NCT06220747 ·Status: RECRUITING
-
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NCT04722822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
NCT06243666 ·Status: ACTIVE_NOT_RECRUITING
-
Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
NCT06776055 ·Status: ACTIVE_NOT_RECRUITING
-
HPV Ends Here: Increasing Uptake of the HPV Vaccine
NCT06831929 ·Status: RECRUITING ·Phase: NA
-
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination
NCT03442062 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
NCT00294047 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
NCT02405221 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors
NCT01492582 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies
NCT05831540 ·Status: TERMINATED ·Phase: NA
-
Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17
NCT02888418 ·Status: UNKNOWN ·Phase: PHASE1
-
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
NCT07104240 ·Status: RECRUITING ·Phase: NA
-
Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
NCT01824537 ·Status: COMPLETED ·Phase: PHASE4
-
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
NCT05985681 ·Status: RECRUITING ·Phase: PHASE1
-
Immunogenicity of Fractional Dose of the HPV Vaccines
NCT05291871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial
NCT02535845 ·Status: TERMINATED ·Phase: NA
-
Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study
NCT02100618 ·Status: WITHDRAWN ·Phase: PHASE3
-
An Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial
NCT04688476 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates
NCT01526551 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting
NCT00572832 ·Status: COMPLETED ·Phase: NA
-
Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine
NCT00359619 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)
NCT00090220 ·Status: COMPLETED ·Phase: PHASE3